Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-25-005314
Filing Date
2025-02-07
Accepted
2025-02-07 09:32:34
Documents
12

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 957457
2 ex5-1.htm EX-5.1 23755
3 ex23-1.htm EX-23.1 4646
4 forms-1_009.jpg GRAPHIC 12000
5 forms-1_001.jpg GRAPHIC 10276
6 vi_001.jpg GRAPHIC 182239
7 vi_002.jpg GRAPHIC 170720
8 vi_003.jpg GRAPHIC 37637
9 vi_004.jpg GRAPHIC 71182
10 vi_005.jpg GRAPHIC 76212
11 vi_006.jpg GRAPHIC 82262
12 ex5-1_001.jpg GRAPHIC 6246
  Complete submission text file 0001493152-25-005314.txt   1881635
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-284032 | Film No.: 25599603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)